Abstract
This case discusses a drug–gene interaction involving and ultraslow metabolism of metoprolol by a cytochrome P450 (CYP) 2D6 allele, leading to excessive bradycardia in the clinical setting of a high dermatomal level of spinal anesthetic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lennard MS, Silas JH, Freestone S, et al. Oxidation phenotype: a major determinant of metoprolol metabolism and response. N Engl J Med. 1982;307:1558–60.
McGourty JC, Silas JH, Lennard MS, et al. Metoprolol metabolism and debrisoquine oxidation polymorphism: population and family studies. Br J Clin Pharmacol. 1985;20:555–66.
Kendall MJ, Maxwell SR, Sandberg A, et al. Controlled release metoprolol: clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet. 1991;21:319–30.
Sachse C, Brockmoller J, Bauer S, et al. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet. 1997;60:284–95.
Rau T, Wuttke H, Michels LM, et al. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study. Clin Pharmacol Ther. 2009;85:269–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cantwell, S.W., Weingarten, T.N., Sprung, J. (2015). Too Slow to Flow. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_127
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7495-1_127
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7494-4
Online ISBN: 978-1-4614-7495-1
eBook Packages: MedicineMedicine (R0)